Xantinol nicotinate

From Self-sufficiency
Revision as of 08:44, 20 September 2010 by Jontas (Talk | contribs) (1 revision)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Xantinol nicotinate
Combination of
Xanthinol vasodilator
Clinical data
Routes of
administration		 Oral
Identifiers
ATC code C04AD02 (WHO)
PubChem CID 9912
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Xantinol nicotinate (or xanthinol niacinate) is a vasodilator. It is a combination of xanthinol and niacin (nicotinic acid).[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


Peripheral vasodilators (C04)
2-amino-1-phenylethanol derivatives
Imidazoline derivatives/
Alpha blockers
Niacin and derivatives
Purine derivatives
Pentifylline · Xantinol nicotinate · Pentoxifylline · Etofylline nicotinate
Ergot alkaloids
Other peripheral vasodilators


30px This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it.
It is a compound of xanthine and nicotinic acid, both of which are vasodilators. It increases blood flow in many vascular beds andhas been promoted for cerebrovascular disorders and PVDs ,but therapeutic benefits are insignificant.
  1. ↑ Xanthinol niacinate at cancerweb.ncl.ac.uk
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Xantinol_nicotinate&oldid=29147"